Manipal Hospitals Initiates IPO Roadshows Aims to Overcome Market Sentiment SP 500 Edges Higher as Healthcare and Tech Lead Gains UK Exports to US Slump 25 Following Trumps Liberation Day Tariffs Trade Deficit Emerges Reddit Stock Drops Nearly 6 Following Metas Launch of Forum App for Facebook Groups Stock Futures Dip as USIran Nuclear Talks Fuel Market Uncertainty Tech Giants Broadcom Meta and Others Invest 125 Million in UCLA Semiconductor Research Hub ARI Q1 2026 Earnings Earnings Miss by 20 as Credit Costs Weigh Stock Edges Higher Piper Sandler PIPR Q1 2026 Earnings EPS Surpasses Expectations with 512 Beat Comstock Inc Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Progress GFF Q1 2026 Earnings Earnings Beat Estimates as EPS Surges Past Consensus Quantum Biopharma Ltd Q4 2025 Earnings Wider Loss as PreRevenue Biotech Navigates Pipeline Progress MSIF Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline Inotiv Inc NOTV Continues Decline Testing Support Near 026 Western Asset Managed Municipals Fund MMU Holds Near Support Amid Modest Decline Bitfarms BITF Remains Flat at 198 as Key Levels Frame a Tight Trading Range Invesco Trust for Investment Grade New York Municipals VTN Edges Higher Amid Municipal Bond Market Stability Corcept Therapeutics CORT Edges Higher Amid Steady Support Levels General Motors Expands Luxury EV Lineup with Cadillac Vistiq Targeting 300Mile Range III Q1 2026 Earnings EPS Surpasses Estimates by 17 as Stock Edges Higher Gabelli Global Small and Mid Cap Value Trust GGZ Edges Higher in Quiet Trading FGBI Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Declines Despite Strong Performance CVR Partners UAN Q1 2026 Earnings Strong PerUnit Income Amid Steady Fertilizer Demand ORIO Q1 2026 Earnings NarrowerthanExpected Loss Lifts Sentiment OPKO Health Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Operational Focus Haymaker Acquisition Corp 4 HYAC Q4 2025 Earnings Strong EPS Beat Driven by NonOperating Income Amid Business Combination Pursuit BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines